Rejuveron Life Sciences AG

Biotechnology company · Schlieren, Zurich, Switzerland

Rejuveron Life Sciences AG is a biotechnology company headquartered in Schlieren, Zurich, Switzerland. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Rejuveron Life Sciences at a glance

Typebiotechnology company

HeadquartersSchlieren, Zurich, Switzerland

Earliest incorporation on record2019

SEC CIK1849162

What does Rejuveron Life Sciences do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.3 million sold (2021).

Frequently asked questions about Rejuveron Life Sciences

Where is Rejuveron Life Sciences headquartered?

Rejuveron Life Sciences AG is headquartered in Schlieren, Zurich, Switzerland.

What does Rejuveron Life Sciences do?

Rejuveron Life Sciences AG is a biotechnology company.

When was Rejuveron Life Sciences founded?

The earliest incorporation on record for Rejuveron Life Sciences AG is in 2019, according to public company registers.

Similar companies

Molecular Partners AgSchlieren, Zurich, Switzerland
CRISPR Therapeutics AGZug, Switzerland
VectivBio Holding AGBasel, Basel-City, Switzerland
LiNA Medical AGRoot, Lucerne, Switzerland
Mymetics CorpEpalinges, Vaud, Switzerland
Polichem SAMendrisio, Ticino, Switzerland
Merck Serono S.A.Geneva, Switzerland
Opna Immuno-Oncology SASt-Sulpice VD, Canton de Vaud, Switzerland

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences